Acasti Pharma Inc
Biotechnology
Healthcare
ACST
7.44 M shares
NASDAQ US
traded
02 Jan 2024
listed
no
open
2.85
52 week high
4.31
high
2.94
52 week low
1.32
previous Close
2.89
P/E ratio
market cap
24.25 M
div yield
0
net incoming
-4.02 M
86.17 %
net profit margin
-402300000.00 %
-90896.00 %
operating incoming
-4.45 M
-114.98 %
net change in cash
-6.24 M
-482.01 %
cash on hand
21.63 M
-22.39 %
cost of revenue
4.45 M
-68.37 %
top